Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/13671
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Reiter, Russel J. | es |
dc.contributor.author | Cardinali, Daniel Pedro | es |
dc.contributor.author | Neel, Richard L. | es |
dc.contributor.author | Domínguez Rodriguez, Alberto | es |
dc.contributor.author | Brown, Gregory M. | es |
dc.contributor.author | Tesarik, Jan | es |
dc.date.accessioned | 2022-03-22T13:57:48Z | - |
dc.date.available | 2022-03-22T13:57:48Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Reiter, R.J. et al. Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 [en línea]. Melatonin Research. 2021, 4 (3). doi: 10.32794/mr112500107. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/13671 | es |
dc.identifier.issn | 2641-0281 (online) | - |
dc.identifier.uri | https://repositorio.uca.edu.ar/handle/123456789/13671 | - |
dc.description.abstract | Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus. | es |
dc.format | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | ST-Bio-Life LLC | es |
dc.rights | Acceso abierto | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.source | Melatonin Research Vol. 4, No.3, 2021 | es |
dc.subject | MELATONINA | es |
dc.subject | SARS-CoV-19 | es |
dc.subject | VARIANTE DELTA COVID-19 | es |
dc.subject | VARIANTES FUTURAS | es |
dc.title | Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 | es |
dc.type | Artículo | es |
dc.identifier.doi | 10.32794/mr112500107 | - |
uca.disciplina | MEDICINA | es |
uca.issnrd | 1 | es |
uca.affiliation | Fil: Reiter, Russel J. University of Texas Health Science Center at San Antonio. Department of Cell Systems and Anatomy; Estados Unidos | es |
uca.affiliation | Fil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina. Facultad de Ciencias Medicas; Argentina | es |
uca.affiliation | Fil: Neel, Richard L. Family Doctor; Estados Unidos | es |
uca.affiliation | Fil: Dominguez Rodriguez, Alberto. University Hospital of Canary Islands San Cristóbal de La Laguna. Department of Cardiology; España | es |
uca.affiliation | Fil: Brown, Gregory M. University of Toronto. Department of Psychiatry; Canada | es |
uca.affiliation | Fil: Tesarik, Jan. MAR & Gen Clinic Granada; España | es |
uca.version | publishedVersion | es |
item.languageiso639-1 | en | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
crisitem.author.dept | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.dept | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.dept | Facultad de Ciencias Médicas | - |
crisitem.author.orcid | 0000-0002-0813-9088 | - |
crisitem.author.parentorg | Facultad de Ciencias Médicas | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
rationale-continued-use-melatonin.pdf | 233,13 kB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
63
comprobado en 27-abr-2024
Descarga(s)
44
comprobado en 27-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons